QNRX Receives FDA Approval
Quoin Pharmaceuticals receives FDA conditional approval of QYLEKI as the proposed brand name for QRX003 for Netherton Syndrome
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.